Rosenberg SA - Search Results

1

Cytokine regulation of tumor necrosis factor-alpha and -beta (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells.

Kasid A, Director EP, Stovroff MC, Lotze MT, Rosenberg SA. Kasid A, et al. Among authors: rosenberg sa. Cancer Res. 1990 Aug 15;50(16):5072-6. Cancer Res. 1990. PMID: 1696166

2

Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans.

Rubin JT, Elwood LJ, Rosenberg SA, Lotze MT. Rubin JT, et al. Among authors: rosenberg sa. Cancer Res. 1989 Dec 15;49(24 Pt 1):7086-92. Cancer Res. 1989. PMID: 2582450

3

Induction of endogenous cytokine-mRNA in circulating peripheral blood mononuclear cells by IL-2 administration to cancer patients.

Kasid A, Director EP, Rosenberg SA. Kasid A, et al. Among authors: rosenberg sa. J Immunol. 1989 Jul 15;143(2):736-9. J Immunol. 1989. PMID: 2661690

4

Colonic perforation. An unusual complication of therapy with high-dose interleukin-2.

Schwartzentruber D, Lotze MT, Rosenberg SA. Schwartzentruber D, et al. Among authors: rosenberg sa. Cancer. 1988 Dec 1;62(11):2350-3. doi: 10.1002/1097-0142(19881201)62:11<2350::aid-cncr2820621116>3.0.co;2-s. Cancer. 1988. PMID: 3263182

5

Retrovirus-mediated gene transfer into CD4+ and CD8+ human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood mononuclear cells.

Morecki S, Karson E, Cornetta K, Kasid A, Aebersold P, Blaese RM, Anderson WF, Rosenberg SA. Morecki S, et al. Among authors: rosenberg sa. Cancer Immunol Immunother. 1991;32(6):342-52. doi: 10.1007/BF01741329. Cancer Immunol Immunother. 1991. PMID: 2007247 Free PMC article.

6

Lymphokine mRNA profile and functional analysis of a human CD4+ clone with unique antitumor specificity isolated from renal cell carcinoma ascitic fluid.

Belldegrun A, Kasid A, Uppenkamp M, Rosenberg SA. Belldegrun A, et al. Among authors: rosenberg sa. Cancer Immunol Immunother. 1990;31(1):1-10. doi: 10.1007/BF01742489. Cancer Immunol Immunother. 1990. PMID: 1968360 Free PMC article.

7

HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapy.

Marincola FM, Venzon D, White D, Rubin JT, Lotze MT, Simonis TB, Balkissoon J, Rosenberg SA, Parkinson DR. Marincola FM, et al. Among authors: rosenberg sa. Cancer Res. 1992 Dec 1;52(23):6561-6. Cancer Res. 1992. PMID: 1423301

8

Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response.

Aebersold P, Hyatt C, Johnson S, Hines K, Korcak L, Sanders M, Lotze M, Topalian S, Yang J, Rosenberg SA. Aebersold P, et al. Among authors: rosenberg sa. J Natl Cancer Inst. 1991 Jul 3;83(13):932-7. doi: 10.1093/jnci/83.13.932. J Natl Cancer Inst. 1991. PMID: 2067036 Clinical Trial.

9

Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.

Wiebke EA, Custer MC, Rosenberg SA, Lotze MT. Wiebke EA, et al. Among authors: rosenberg sa. J Biol Response Mod. 1990 Apr;9(2):113-26. J Biol Response Mod. 1990. PMID: 2111373

10

Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for immunotherapeutic failures.

Topalian SL, Kasid A, Rosenberg SA. Topalian SL, et al. Among authors: rosenberg sa. J Immunol. 1990 Jun 1;144(11):4487-95. J Immunol. 1990. PMID: 2160503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,359 results

Search Page

Filters